rhythmera4
About
Cytopathic outcomes and native defense replies within repetitive neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic outcomes and native defense replies within repetitive neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.